Description :
Progynova contains Estradiol Valerate, a form of estrogen hormone replacement therapy (HRT). It is commonly prescribed to relieve symptoms of menopause (such as hot flashes, vaginal dryness, and night sweats), to prevent postmenopausal osteoporosis, and sometimes as part of hormone therapy in women with ovarian failure or after hysterectomy. It may also be used in gender-affirming hormone therapy.
---
Dosage (General Use):
Typical dose: 1–2 mg orally once daily.
Treatment duration and dose are adjusted individually by a doctor.
Should be taken at the same time each day, with or without food.
(Exact dose must be prescribed by a healthcare professional.)
---
Precautions & Warnings:
Contraindicated in women with breast cancer, estrogen-dependent tumors, unexplained vaginal bleeding, liver disease, or history of blood clots/stroke.
Long-term use may increase the risk of endometrial, breast, and ovarian cancer.
Use with caution in women with hypertension, diabetes, migraines, or heart disease.
Regular medical check-ups (breast exam, pelvic exam, blood pressure monitoring) are recommended.
Not for use during pregnancy or breastfeeding.
---
Possible Side Effects:
Common: Headache, nausea, breast tenderness, weight changes, mood swings.
Fluid retention, leg cramps, or bloating.
Breakthrough bleeding or spotting.
Rare but serious: Blood clots, stroke, heart attack, liver problems.
